TPIV TapImmune, Inc. $TPIV Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
TPIV TapImmune, Inc. $TPIV Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=TPIV&...mp;yt0=Go!

Last Updated: 05/17/2015 16:18:19

Current Price and Quotes
Last Price 0.295
Previous Close 0.2841 Open 0.285
Daily Range 0.273 - 0.298 52wk Range 0.121 - 2.70
Volume 652,612 Dividend N/A
Average Vol (30d) 598,089 Net Dividend Yield N/A




Financials

Recent News
Source
May 15, 2015 Phase I Study in Ovarian & Breast Cancer Published in Abstracts of 2015 ASCO Annual Meeting PR NEWSWIRE
May 13, 2015 Despite Unimpressive Company Guidance Shares Soar BrokerBank Securities [Market News Publishing (US)] Market News
May 12, 2015 OTC Short Positions on 2015/04/30 44,582 44,282 0.20 [Market News Publishing (US)] Market News
Apr 27, 2015 OTC Short Positions on 2015/04/15 300 -37,266 0.20 [Market News Publishing (US)] Market News
Apr 13, 2015 OTC Short Positions on 2015/03/31 37,566 4,638 0.21 [Market News Publishing (US)] Market News
Mar 31, 2015 Presentation at the Maidstone Life Sciences 'Cancer Immunotherapy: A Long Awaited Reality' [Market News Publishing (US)] Market News
Mar 30, 2015 Presentation at the Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" PR NEWSWIRE
Mar 25, 2015 To Present at the Maidstone Life Sciences "Cancer Immunotherapy: A Long Awaited Reality" on Thursday March 26, 2015 [Market News Publishing (US)] Market News
Mar 25, 2015 TapImmune to Present at the Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" on Thursday March 26, 2015 PR NEWSWIRE
Mar 25, 2015 OTC Short Positions on 2015/03/13 32,928 -8,160 0.21 [Market News Publishing (US)] Market News

1
2
3
next >

TPIV TapImmune, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=TPIV&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/TPIV/quote
Stock Chart http://www.otcmarkets.com/stock/TPIV/chart
Company Info http://www.otcmarkets.com/stock/TPIV/company-info
Recent News http://www.otcmarkets.com/stock/TPIV/news
Financials http://www.otcmarkets.com/stock/TPIV/financials
Filings and Disclosure http://www.otcmarkets.com/stock/TPIV/filings
Short Sales http://www.otcmarkets.com/stock/TPIV/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/TPIV/insider-transactions
Research Reports http://www.otcmarkets.com/stock/TPIV/research
Summary http://finance.yahoo.com/q?s=TPIV
Historical Prices http://finance.yahoo.com/q/hp?s=TPIV+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=TPIV
Basic Chart http://finance.yahoo.com/q/bc?s=TPIV+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=TPIV+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=TPIV+Headlines
Press Releases http://finance.yahoo.com/q/p?s=TPIV+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=TPIV+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=TPIV+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=TPIV+Industry
Major Holders http://finance.yahoo.com/q/mh?s=TPIV+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=TPIV+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=TPIV+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=TPIV
Balance Sheet http://finance.yahoo.com/q/bs?s=TPIV
Cash Flow http://finance.yahoo.com/q/cf?s=TPIV+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/TPIV
Market Watch http://www.marketwatch.com/investing/stock/TPIV
Bloomberg http://www.bloomberg.com/quote/TPIV:US
Morningstar http://quotes.morningstar.com/stock/s?t=TPIV
Bussinessweek http://investing.businessweek.com/research/st...icker=TPIV
Barchart http://www.barchart.com/quotes/stocks/TPIV
OTC Short Report http://otcshortreport.com/index.php?index=TPIV
Investopedia http://www.investopedia.com/markets/stocks/TPIV/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading